Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction of Erlocip 150 mg Tablet:
Erlocip 150 mg Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer.
Erlocip 150 mg Tablet should be taken while fasting or should be taken one hour before or two hours after a meal. You should continue taking it as long as your doctor advises. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your physician has advised. Misinterpreting the dosage or taking too much can cause severe side effects. It may take several weeks or months for you to see or feel the benefits, but do not stop taking it unless your doctor tells you to.
Uses of Erlocip 150 mg Tablet:
Lung cancer
Pancreatic cancer
Benefits of Erlocip 150 mg Tablet:
In Lung cancer:
Erlocip 150 mg Tablet helps treat non-small cell lung cancer and may be administered alone or in combination with other medications. It is an effective and highly toxic drug, and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while undergoing this treatment and drink plenty of water to stay hydrated.
In Pancreatic cancer:
Erlocip 150 mg Tablet assists in halting the action of the chemicals that aid in pancreatic cancer growth and spread. It will help you live a longer and better life.
Mechanism of Erlocip 150 mg Tablet:
Erlocip 150 mg Tablet is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are expressed on the surfaces of lung cancer cells that regulate their growth. This medication works by binding to the enzyme messenger, EGFR, thereby inhibiting the cancer signaling pathways mediated by EGFR. This is how it limits further growth of the cancer cells.